Swedish Pharmaceuticals & Biotech Price disconnect

Results

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

3 companies

Swedencare

Market Cap: SEK 3.4b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 21.85

2.3%

-42.3%

Cantargia

Market Cap: SEK 423.9m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

CANTA

SEK 1.75

-3.3%

-36.9%

Sprint Bioscience

Market Cap: SEK 349.3m

A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

SPRINT

SEK 3.29

1.9%

455.7%